ResearcherFirst Affiliated Hospital of Henan University of Science and TechnologyNo recent work listed

Ce Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-7350-4187; OpenAlex author ID A5009708233. Sources: OpenAlex.

Their work

Papers: 2 (first author 1, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2018: 1 paper · 2019: 1 paper

Papers 2

Downregulation of circular RNA circ-LDLRAD3 suppresses pancreatic cancer progression through miR-137-3p/PTN axis. First author DOI 10.1016/j.lfs.2019.116871 ↗
Micro-RNA-21 Regulates Cancer-Associated Fibroblast-Mediated Drug Resistance in Pancreatic Cancer. Last author DOI 10.3727/096504017x14934840662335 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Jun Yao · 2 shared papers, 2018–2019 · strength 0.26
- Paper Downregulation of circular RNA circ-LDLRAD3 suppresses pancreatic cancer progression through miR-137-3p/PTN axis. DOI 10.1016/j.lfs.2019.116871 ↗
- Paper Micro-RNA-21 Regulates Cancer-Associated Fibroblast-Mediated Drug Resistance in Pancreatic Cancer. DOI 10.3727/096504017x14934840662335 ↗
Shegan Gao · 1 shared paper, 2019 · strength 0.14
- Paper Downregulation of circular RNA circ-LDLRAD3 suppresses pancreatic cancer progression through miR-137-3p/PTN axis. DOI 10.1016/j.lfs.2019.116871 ↗
Lulin Zhang · 1 shared paper, 2018 · strength 0.12
- Paper Micro-RNA-21 Regulates Cancer-Associated Fibroblast-Mediated Drug Resistance in Pancreatic Cancer. DOI 10.3727/096504017x14934840662335 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.